Your browser doesn't support javascript.
loading
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.
Alves, Fabiana; Bilbe, Graeme; Blesson, Séverine; Goyal, Vishal; Monnerat, Séverine; Mowbray, Charles; Muthoni Ouattara, Gina; Pécoul, Bernard; Rijal, Suman; Rode, Joelle; Solomos, Alexandra; Strub-Wourgaft, Nathalie; Wasunna, Monique; Wells, Susan; Zijlstra, Eduard E; Arana, Byron; Alvar, Jorge.
Afiliación
  • Alves F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Bilbe G; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Blesson S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Goyal V; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Monnerat S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Mowbray C; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Muthoni Ouattara G; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Pécoul B; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Rijal S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Rode J; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Solomos A; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Strub-Wourgaft N; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Wasunna M; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Wells S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Zijlstra EE; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Arana B; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Alvar J; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland jalvar@dndi.org.
Clin Microbiol Rev ; 31(4)2018 10.
Article en En | MEDLINE | ID: mdl-30158301

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Descubrimiento de Drogas / Leishmaniasis Visceral / Antiprotozoarios Límite: Humans Idioma: En Revista: Clin Microbiol Rev Asunto de la revista: MICROBIOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Descubrimiento de Drogas / Leishmaniasis Visceral / Antiprotozoarios Límite: Humans Idioma: En Revista: Clin Microbiol Rev Asunto de la revista: MICROBIOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Suiza